Breast cancer (BC) is a heterogeneous tumor, and better understanding of its heterogeneity is essential to improving treatment effect. Quantum dot (QD)-based immunofluorescent nanotechnology (QD-IHC) for molecular pathology has potential advantages in delineating tumor heterogeneity. This potential is explored in this paper by QD-IHC imaging of HER2 and ER. BC heterogeneity can be displayed more clearly and sensitively by QD-IHC than conventional IHC in BC tissue microarrays. Furthermore, the simultaneous imaging of ER and HER2 might help understand their interactions during the process of evolution of heterogeneous BC.
Introduction
Breast cancer (BC) is a heterogeneous tumor, and better understanding of its heterogeneity is essential for improving treatment effect [1] [2] [3] . Quantum dot (QD)-based nanotechnology has potential advantages for further understanding tumor heterogeneity [4] [5] [6] . This technique has achieved encouraging developments in in vivo and in vitro molecular and cellular imaging in cancer research, which will have a positive impact on cancer pathogenesis, early diagnosis, targeted therapy, monitoring and prognosis [7] [8] [9] . 8 Authors to whom any correspondence should be addressed.
Bioconjugation of QDs with antigens and antibodies could offer a new pathway to enhanced sensing and imaging technologies [10] . In previous molecular targeted imaging of cancer cells [11] [12] [13] , we demonstrated that in molecular pathology QD-based probes have advantages such as higher fluorescent efficiency over organic fluorescent dyes, greater adaptability for real-time multicolor fluorescent imaging using a single wavelength excitation light source, and higher photostability for long-term imaging of tumor markers. Therefore, we further developed standard protocols for in vitro cellular imaging and in vivo imaging of liver cancer xenograft models. It was found that the heterogeneity of alpha-fetoprotein marker distribution in xenografts could more clearly and sensitively by QD-IHC. Furthermore, the simultaneous imaging of ER and HER2 might help understand their interactions during the process of evolution of BC heterogeneity. Therefore, this technique provides new insights into BC heterogeneity.
